Evidence map›Paper›PMID 42123427›Full record

ArticleInternational journal of molecular sciences2026

Plasma Proteomic Signatures of Glucose Metabolism Disturbances and Early Diabetes.

Natalia Zieleniewska, Jacek Jamiołkowski, Anders Malarstig, Klev Diamanti, Małgorzata Chlabicz, Marcin Kondraciuk, Kerhan Woo, Irina Kowalska, Karol Kamiński

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natalia ZieleniewskaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.
Jacek JamiołkowskiDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.
Anders MalarstigDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Nobels Road 12A, 171 65 Stockholm, Sweden.ORCID 0000-0003-2608-1358
Klev DiamantiOlink, Part of Thermo Fisher Scientific, Salagatan 16A, 753 30 Uppsala, Sweden.
Małgorzata ChlabiczDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.ORCID 0000-0002-5113-5672
Marcin KondraciukDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.ORCID 0000-0002-4516-7467
Kerhan WooOlink, Part of Thermo Fisher Scientific, Salagatan 16A, 753 30 Uppsala, Sweden.
Irina KowalskaDepartment of Internal Medicine and Metabolic Diseases, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.ORCID 0000-0001-9281-1959
Karol KamińskiDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Białystok, Waszyngtona 15B Street, 15-269 Bialystok, Poland.ORCID 0000-0002-9465-2581

Funding

Medical University of Bialystok B.SUB.24.506
6 · The paper itself

Abstract

Postprandial variability in glucose and protein levels is one of the elements of insulin resistance (IR) and prediabetes, which is an area precursor to type 2 diabetes mellitus (DM). The objective of the study was a comprehensive proteomic analysis according to glucose tolerance in the general population who did not self-report DM or other diseases. We used Olink

Indexed as

Blood ProteinsGlucose Metabolism DisordersProteomeAdultBiomarkersFemaleHumansMaleMiddle AgedBiomarkersBlood ProteinsProteomebiomarkersdiabetes type 2prediabetesproteomic profiling

Identifiers

PMID42123427
PMCPMC13163269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.